MSB 0.00% $2.81 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-524

  1. 17,289 Posts.
    lightbulb Created with Sketch. 2450
    "Jb1975 is there a better alternative to treat paediatric SR aGvHD than Remestemcel-l "

    Well so far it hasn't been convincingly demonstrated to be any more efficacious than using Medicinal Compound (Lily The Pink Inc)

    Until the FDA have received a successful RCT that improves on the previous two trials by Osiris, that's still the most likely verdict.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$2.81
Change
0.000(0.00%)
Mkt cap ! $3.222B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1130 $3.08
 

Sellers (Offers)

Price($) Vol. No.
$2.53 10 1
View Market Depth
Last trade - 16.17pm 10/01/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.